Alphabetic Index |
Tabular List |
Neoplasms |
Drugs and Chemicals |
Injuries
I27
Other pulmonary heart diseases
I27.0
Primary pulmonary hypertension
persistent pulmonary hypertension of newborn (P29.30)
pulmonary hypertension NOS (I27.20)
secondary pulmonary arterial hypertension (I27.21)
secondary pulmonary hypertension (I27.29)
Heritable pulmonary arterial hypertension
Idiopathic pulmonary arterial hypertension
Primary group 1 pulmonary hypertension
Primary pulmonary arterial hypertension
I27.1
Kyphoscoliotic heart disease
I27.2
Other secondary pulmonary hypertension
associated underlying condition
Eisenmenger's syndrome (I27.83)
I27.20
Pulmonary hypertension, unspecified
Pulmonary hypertension NOS
I27.21
Secondary pulmonary arterial hypertension
associated conditions if applicable, or adverse effects of drugs or toxins, such as:
adverse effect of appetite depressants (T50.5X5)
congenital heart disease (Q20-Q28)
human immunodeficiency virus [HIV] disease (B20)
polymyositis (M33.2-)
portal hypertension (K76.6)
rheumatoid arthritis (M05.-)
schistosomiasis (B65.-)
Sjögren syndrome (M35.0-)
systemic sclerosis (M34.-)
(Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS
(Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension
I27.22
Pulmonary hypertension due to left heart disease
associated left heart disease, if known, such as:
multiple valve disease (I08.-)
rheumatic mitral valve diseases (I05.-)
rheumatic aortic valve diseases (I06.-)
Group 2 pulmonary hypertension
I27.23
Pulmonary hypertension due to lung diseases and hypoxia
associated lung disease, if known, such as:
bronchiectasis (J47.-)
cystic fibrosis with pulmonary manifestations (E84.0)
interstitial lung disease (J84.-)
pleural effusion (J90)
sleep apnea (G47.3-)
Group 3 pulmonary hypertension
I27.24
Chronic thromboembolic pulmonary hypertension
associated pulmonary embolism, if applicable (I26.-, I27.82)
Group 4 pulmonary hypertension
I27.29
Other secondary pulmonary hypertension
other associated disorders, if known, such as:
chronic myeloid leukemia (C92.10- C92.22)
essential thrombocythemia (D47.3)
Gaucher disease (E75.22)
hypertensive chronic kidney disease with end stage renal disease (I12.0, I13.11, I13.2)
hyperthyroidism (E05.-)
hypothyroidism (E00-E03)
polycythemia vera (D45)
sarcoidosis (D86.-)
Group 5 pulmonary hypertension
Pulmonary hypertension with unclear multifactorial mechanisms
Pulmonary hypertension due to hematologic disorders
Pulmonary hypertension due to metabolic disorders
Pulmonary hypertension due to other systemic disorders
I27.8
Other specified pulmonary heart diseases
I27.81
Cor pulmonale (chronic)
acute cor pulmonale (I26.0-)
Cor pulmonale NOS
I27.82
Chronic pulmonary embolism
personal history of pulmonary embolism (Z86.711)
I27.83
Eisenmenger's syndrome
underlying heart defect, if known, such as:
atrial septal defect (Q21.1)
Eisenmenger's defect (Q21.8)
patent ductus arteriosus (Q25.0)
ventricular septal defect (Q21.0)
Eisenmenger's complex
(Irreversible) Eisenmenger's disease
Pulmonary hypertension with right to left shunt related to congenital heart disease
I27.89
Other specified pulmonary heart diseases
I27.9
Pulmonary heart disease, unspecified
Chronic cardiopulmonary disease